Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 107 of 107 entries
Sorted by: Best Match Show Resources per page
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS.
PMID: 33624751
Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172.

BACKGROUND: Assessing the duration of immunity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of protection following infection. Such knowledge is lacking, especially in the general population. Here, we...

Cite
den Hartog G, Vos ERA, van den Hoogen LL, et al. Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clin Infect Dis. 2021;73(12):2155-2162doi: 10.1093/cid/ciab172.
den Hartog, G., Vos, E. R. A., van den Hoogen, L. L., van Boven, M., Schepp, R. M., Smits, G., van Vliet, J., Woudstra, L., Wijmenga-Monsuur, A. J., van Hagen, C. C. E., Sanders, E. A. M., de Melker, H. E., van der Klis, F. R. M., & van Binnendijk, R. S. (2021). Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(12), 2155-2162. https://doi.org/10.1093/cid/ciab172
den Hartog, Gerco, et al. "Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,12 (2021): 2155-2162. doi: https://doi.org/10.1093/cid/ciab172
den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS. Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172. PMID: 33624751; PMCID: PMC7929058.
Copy Download .nbib Format: NLM
Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?.

The EPMA journal

Berger JS, Haskell L, Ting W, Lurie F, Chang SC, Mueller LA, Elder K, Rich K, Crivera C, Schein JR, Alas V.
PMID: 32140185
EPMA J. 2020 Jan 03;11(1):53-64. doi: 10.1007/s13167-019-00196-9. eCollection 2020 Mar.

BACKGROUND: Critical limb ischemia (CLI) is a severe stage of peripheral arterial disease and has a substantial disease and economic burden not only to patients and families, but also to the society and healthcare systems. We aim to develop...

Cite
Berger JS, Haskell L, Ting W, et al. Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?. EPMA J. 2020;11(1):53-64doi: 10.1007/s13167-019-00196-9.
Berger, J. S., Haskell, L., Ting, W., Lurie, F., Chang, S. C., Mueller, L. A., Elder, K., Rich, K., Crivera, C., Schein, J. R., & Alas, V. (2020). Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?. The EPMA journal, 11(1), 53-64. https://doi.org/10.1007/s13167-019-00196-9
Berger, Jeffrey S, et al. "Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?." The EPMA journal vol. 11,1 (2020): 53-64. doi: https://doi.org/10.1007/s13167-019-00196-9
Berger JS, Haskell L, Ting W, Lurie F, Chang SC, Mueller LA, Elder K, Rich K, Crivera C, Schein JR, Alas V. Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia-is preventive and personalized approach on the horizon?. EPMA J. 2020 Jan 03;11(1):53-64. doi: 10.1007/s13167-019-00196-9. eCollection 2020 Mar. PMID: 32140185; PMCID: PMC7028871.
Copy Download .nbib Format: NLM
Correlation of the 15N(i + 1), 13Calpha(i), and 1Halpha(i) Backbone Resonances in 13C/15N-Labeled Proteins by the (CO)N(CO)CAH Experiment.

Journal of magnetic resonance (San Diego, Calif. : 1997)

Dijkstra K, Kroon GJA, Ab E, Scheek RM, Kemmink J.
PMID: 9245371
J Magn Reson. 1997 Mar;125(1):149-52. doi: 10.1006/jmre.1996.1096.

No abstract available.

Cite
Dijkstra K, Kroon GJA, Ab E, et al. Correlation of the 15N(i + 1), 13Calpha(i), and 1Halpha(i) Backbone Resonances in 13C/15N-Labeled Proteins by the (CO)N(CO)CAH Experiment. J Magn Reson. 1997;125(1):149-52doi: 10.1006/jmre.1996.1096.
Dijkstra, K., Kroon, G. J. A., Ab, E., Scheek, R. M., & Kemmink, J. (1997). Correlation of the 15N(i + 1), 13Calpha(i), and 1Halpha(i) Backbone Resonances in 13C/15N-Labeled Proteins by the (CO)N(CO)CAH Experiment. Journal of magnetic resonance (San Diego, Calif. : 1997), 125(1), 149-52. https://doi.org/10.1006/jmre.1996.1096
Dijkstra, et al. "Correlation of the 15N(i + 1), 13Calpha(i), and 1Halpha(i) Backbone Resonances in 13C/15N-Labeled Proteins by the (CO)N(CO)CAH Experiment." Journal of magnetic resonance (San Diego, Calif. : 1997) vol. 125,1 (1997): 149-52. doi: https://doi.org/10.1006/jmre.1996.1096
Dijkstra K, Kroon GJA, Ab E, Scheek RM, Kemmink J. Correlation of the 15N(i + 1), 13Calpha(i), and 1Halpha(i) Backbone Resonances in 13C/15N-Labeled Proteins by the (CO)N(CO)CAH Experiment. J Magn Reson. 1997 Mar;125(1):149-52. doi: 10.1006/jmre.1996.1096. PMID: 9245371.
Copy Download .nbib Format: NLM
Repurposing approved drugs for cancer therapy.

British medical bulletin

Schein CH.
PMID: 33517358
Br Med Bull. 2021 Mar 25;137(1):13-27. doi: 10.1093/bmb/ldaa045.

BACKGROUND: Many drugs approved for other indications can control the growth of tumor cells and limit adverse events (AE).DATA SOURCES: Literature searches with keywords 'repurposing and cancer' books, websites: https://clinicaltrials.gov/, for drug structures: https://pubchem.ncbi.nlm.nih.gov/.AREAS OF AGREEMENT: Introducing approved drugs,...

Cite
Schein CH. Repurposing approved drugs for cancer therapy. Br Med Bull. 2021;137(1):13-27doi: 10.1093/bmb/ldaa045.
Schein, C. H. (2021). Repurposing approved drugs for cancer therapy. British medical bulletin, 137(1), 13-27. https://doi.org/10.1093/bmb/ldaa045
Schein, Catherine H. "Repurposing approved drugs for cancer therapy." British medical bulletin vol. 137,1 (2021): 13-27. doi: https://doi.org/10.1093/bmb/ldaa045
Schein CH. Repurposing approved drugs for cancer therapy. Br Med Bull. 2021 Mar 25;137(1):13-27. doi: 10.1093/bmb/ldaa045. PMID: 33517358; PMCID: PMC7929227.
Copy Download .nbib Format: NLM
Gastrointestinal comorbidities associated with atrial fibrillation.

SpringerPlus

Laliberté F, Moore Y, Dea K, LaMori JC, Mody SH, Jones JL, Arledge MD, Damaraju CV, Schein JR, Lefebvre P.
PMID: 25392776
Springerplus. 2014 Oct 15;3:603. doi: 10.1186/2193-1801-3-603. eCollection 2014.

This observational study was conducted to describe the risk of gastrointestinal (GI) events among patients with atrial fibrillation (AF). We analyzed Thomson Reuters MarketScan® data from 2005 to 2009. Subjects aged ≥18 years with ≥ 1 AF diagnosis were...

Cite
Laliberté F, Moore Y, Dea K, et al. Gastrointestinal comorbidities associated with atrial fibrillation. Springerplus. 2014;3:603doi: 10.1186/2193-1801-3-603.
Laliberté, F., Moore, Y., Dea, K., LaMori, J. C., Mody, S. H., Jones, J. L., Arledge, M. D., Damaraju, C. V., Schein, J. R., & Lefebvre, P. (2014). Gastrointestinal comorbidities associated with atrial fibrillation. SpringerPlus, 3603. https://doi.org/10.1186/2193-1801-3-603
Laliberté, François, et al. "Gastrointestinal comorbidities associated with atrial fibrillation." SpringerPlus vol. 3 (2014): 603. doi: https://doi.org/10.1186/2193-1801-3-603
Laliberté F, Moore Y, Dea K, LaMori JC, Mody SH, Jones JL, Arledge MD, Damaraju CV, Schein JR, Lefebvre P. Gastrointestinal comorbidities associated with atrial fibrillation. Springerplus. 2014 Oct 15;3:603. doi: 10.1186/2193-1801-3-603. eCollection 2014. PMID: 25392776; PMCID: PMC4210454.
Copy Download .nbib Format: NLM
Intensive Blood-Pressure Lowering in Cerebral Hemorrhage.

The New England journal of medicine

Quartin A, Schein R.
PMID: 28112902
N Engl J Med. 2016 Dec 08;375(23):e48. doi: 10.1056/NEJMc1613117.

No abstract available.

Cite
Quartin A, Schein R. Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med. 2016;375(23):e48doi: 10.1056/NEJMc1613117.
Quartin, A., & Schein, R. (2016). Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. The New England journal of medicine, 375(23), e48. https://doi.org/10.1056/NEJMc1613117
Quartin, Andrew, and Schein, Roland. "Intensive Blood-Pressure Lowering in Cerebral Hemorrhage." The New England journal of medicine vol. 375,23 (2016): e48. doi: https://doi.org/10.1056/NEJMc1613117
Quartin A, Schein R. Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med. 2016 Dec 08;375(23):e48. doi: 10.1056/NEJMc1613117. PMID: 28112902.
Copy Download .nbib Format: NLM
Diagnosis of spinal epidural abscess: a case report and literature review.

Spinal cord series and cases

Chima-Melton C, Pearl M, Scheiner M.
PMID: 28435744
Spinal Cord Ser Cases. 2017 Apr 06;3:17013. doi: 10.1038/scsandc.2017.13. eCollection 2017.

INTRODUCTION: Spinal epidural abscess (SEA) is a rare but serious cause of back pain in the critical care setting. It occurs most commonly in adults in their fifth and sixth decades of life. Risk factors include diabetes mellitus, alcoholism,...

Cite
Chima-Melton C, Pearl M, Scheiner M. Diagnosis of spinal epidural abscess: a case report and literature review. Spinal Cord Ser Cases. 2017;3:17013doi: 10.1038/scsandc.2017.13.
Chima-Melton, C., Pearl, M., & Scheiner, M. (2017). Diagnosis of spinal epidural abscess: a case report and literature review. Spinal cord series and cases, 317013. https://doi.org/10.1038/scsandc.2017.13
Chima-Melton, Chidinma, et al. "Diagnosis of spinal epidural abscess: a case report and literature review." Spinal cord series and cases vol. 3 (2017): 17013. doi: https://doi.org/10.1038/scsandc.2017.13
Chima-Melton C, Pearl M, Scheiner M. Diagnosis of spinal epidural abscess: a case report and literature review. Spinal Cord Ser Cases. 2017 Apr 06;3:17013. doi: 10.1038/scsandc.2017.13. eCollection 2017. PMID: 28435744; PMCID: PMC5382353.
Copy Download .nbib Format: NLM
Development of a Home-Based Telerehabilitation Service Delivery Protocol for Wheelchair Seating and Mobility Within the Veterans Health Administration.

Military medicine

Ott KK, Schein RM, Straatmann J, Schmeler MR, Dicianno BE.
PMID: 33647955
Mil Med. 2021 Feb 27; doi: 10.1093/milmed/usab091. Epub 2021 Feb 27.

INTRODUCTION: The provision of seating and wheeled mobility devices is a complex process that requires trained professionals and multiple appointments throughout the service delivery process. However, this can be inconvenient and burdensome for individuals with mobility limitations or for...

Cite
Ott KK, Schein RM, Straatmann J, et al. Development of a Home-Based Telerehabilitation Service Delivery Protocol for Wheelchair Seating and Mobility Within the Veterans Health Administration. Mil Med. 2021;doi: 10.1093/milmed/usab091.
Ott, K. K., Schein, R. M., Straatmann, J., Schmeler, M. R., & Dicianno, B. E. (2021). Development of a Home-Based Telerehabilitation Service Delivery Protocol for Wheelchair Seating and Mobility Within the Veterans Health Administration. Military medicine, . https://doi.org/10.1093/milmed/usab091
Ott, Kaila K, et al. "Development of a Home-Based Telerehabilitation Service Delivery Protocol for Wheelchair Seating and Mobility Within the Veterans Health Administration." Military medicine vol. (2021). doi: https://doi.org/10.1093/milmed/usab091
Ott KK, Schein RM, Straatmann J, Schmeler MR, Dicianno BE. Development of a Home-Based Telerehabilitation Service Delivery Protocol for Wheelchair Seating and Mobility Within the Veterans Health Administration. Mil Med. 2021 Feb 27; doi: 10.1093/milmed/usab091. Epub 2021 Feb 27. PMID: 33647955.
Copy Download .nbib Format: NLM
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS.
PMID: 33624751
Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172.

BACKGROUND: Assessing the duration of immunity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of protection following infection. Such knowledge is lacking, especially in the general population. Here, we...

Cite
den Hartog G, Vos ERA, van den Hoogen LL, et al. Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clin Infect Dis. 2021;73(12):2155-2162doi: 10.1093/cid/ciab172.
den Hartog, G., Vos, E. R. A., van den Hoogen, L. L., van Boven, M., Schepp, R. M., Smits, G., van Vliet, J., Woudstra, L., Wijmenga-Monsuur, A. J., van Hagen, C. C. E., Sanders, E. A. M., de Melker, H. E., van der Klis, F. R. M., & van Binnendijk, R. S. (2021). Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(12), 2155-2162. https://doi.org/10.1093/cid/ciab172
den Hartog, Gerco, et al. "Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,12 (2021): 2155-2162. doi: https://doi.org/10.1093/cid/ciab172
den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS. Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study. Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172. PMID: 33624751; PMCID: PMC7929058.
Copy Download .nbib Format: NLM
Functional Mobility Outcomes in Telehealth and In-Person Assessments for Wheeled Mobility Devices.

International journal of telerehabilitation

Bell M, Schein RM, Straatmann J, Dicianno BE, Schmeler MR.
PMID: 33520092
Int J Telerehabil. 2020 Dec 08;12(2):27-34. doi: 10.5195/ijt.2020.6335.

The purpose of this study was to compare telehealth and in-person service delivery models for wheeled mobility devices in terms of functional outcomes. We hypothesized that clinically significant improvements in functional mobility measured by the Functional Mobility Assessment (FMA)...

Cite
Bell M, Schein RM, Straatmann J, et al. Functional Mobility Outcomes in Telehealth and In-Person Assessments for Wheeled Mobility Devices. Int J Telerehabil. 2020;12(2):27-34doi: 10.5195/ijt.2020.6335.
Bell, M., Schein, R. M., Straatmann, J., Dicianno, B. E., & Schmeler, M. R. (2020). Functional Mobility Outcomes in Telehealth and In-Person Assessments for Wheeled Mobility Devices. International journal of telerehabilitation, 12(2), 27-34. https://doi.org/10.5195/ijt.2020.6335
Bell, Mitchell, et al. "Functional Mobility Outcomes in Telehealth and In-Person Assessments for Wheeled Mobility Devices." International journal of telerehabilitation vol. 12,2 (2020): 27-34. doi: https://doi.org/10.5195/ijt.2020.6335
Bell M, Schein RM, Straatmann J, Dicianno BE, Schmeler MR. Functional Mobility Outcomes in Telehealth and In-Person Assessments for Wheeled Mobility Devices. Int J Telerehabil. 2020 Dec 08;12(2):27-34. doi: 10.5195/ijt.2020.6335. PMID: 33520092; PMCID: PMC7757644.
Copy Download .nbib Format: NLM
Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients.

Annals of vascular surgery

Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D.
PMID: 34474131
Ann Vasc Surg. 2021 Aug 30; doi: 10.1016/j.avsg.2021.06.020. Epub 2021 Aug 30.

BACKGROUND: To report technical and clinical 30-day results following treatment with the Zenith Alpha™ abdominal stent graft from the ZEnith alPHa for aneurYsm Repair Registry (ZEPHYR).METHODS: Multicenter, nonrandomized, single arm, core laboratory-controlled, prospective registry collecting data on the Zenith...

Cite
Hatzl J, Batenburg MVB, Yeung KK, et al. Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Ann Vasc Surg. 2021;doi: 10.1016/j.avsg.2021.06.020.
Hatzl, J., Batenburg, M. V. B., Yeung, K. K., Fioole, B., Verhoeven, E., Lauwers, G., Kölbel, T., Wever, J. J., Scheinert, D., Van den Eynde, W., Rouhani, G., Mees, B. M. E., Vermassen, F., Schelzig, H., Cuypers, P. W. M., Böckler, D. (2021). Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Annals of vascular surgery, . https://doi.org/10.1016/j.avsg.2021.06.020
Hatzl, Johannes, et al. "Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients." Annals of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.avsg.2021.06.020
Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D. Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients. Ann Vasc Surg. 2021 Aug 30; doi: 10.1016/j.avsg.2021.06.020. Epub 2021 Aug 30. PMID: 34474131.
Copy Download .nbib Format: NLM
Showing 97 to 107 of 107 entries